PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcmPermissionsJournals.ASM.orgJournalJCM ArticleJournal InfoAuthorsReviewers
 
J Clin Microbiol. 2010 February; 48(2): 675–676.
Published online 2009 December 2. doi:  10.1128/JCM.01443-09
PMCID: PMC2815620

Putative Link between the Virulence-Associated fluA Gene and Fluoroquinolone Resistance in Uropathogenic Escherichia coli[down-pointing small open triangle]

Resistance to fluoroquinolones is a major problem in the treatment of various infectious diseases, including urinary tract infections (UTI) caused by Escherichia coli. It has been recognized that fluoroquinolone-resistant E. coli strains generally harbor fewer virulence genes than their susceptible counterparts (2, 4, 5, 7, 8).

We observed an increased prevalence of the virulence-associated fluA gene, which encodes the autotransporter protein Ag43a (9), in E. coli isolated in 2006 to 2008 compared to that in isolates collected prior to fluoroquinolone use (1983 to 1986). This increase was seen only in E. coli isolated from patients with urosepticemia, displaying a fluoroquinolone resistance rate of 26%, but not among isolates from patients with UTI, all of which were sensitive to these agents. Interestingly, 11 of the 12 resistant isolates carried fluA. We therefore chose to study a set of resistant and sensitive strains from patients with urosepticemia for a possible association between fluA and fluoroquinolone resistance.

A total of 34 sensitive and 57 resistant E. coli isolates collected from patients with urosepticemia between 2000 and 2009 at the Karolinska University Hospital Solna, Stockholm, Sweden, were investigated. Fluoroquinolone resistance was determined according to guidelines of the Swedish Reference Group for Antibiotics (www.srga.org). Isolates sensitive to ciprofloxacin but resistant to nalidixic acid were considered resistant after confirmation of target alteration by sequencing (10). The presence of fluA was determined by PCR (9), and isolates were assigned to phylogenetic group A, B1, B2, or D by multiplex PCR (1). Prevalence data were compared by using Fisher's exact test or the chi-square test, as appropriate. Differences with P values of <0.05 were considered statistically significant.

The frequency of phylogenetic groups B2 and D differed significantly between the resistant and sensitive populations (Table (Table1).1). While the sensitive isolates mostly belonged to group B2, the resistant ones were associated with group D. This distribution is in line with previous studies (4, 5, 7, 8).

TABLE 1.
Distribution of phylogenetic groups and fluA in relation to susceptibility to fluoroquinolones

As indicated by our initial observation, the prevalence of fluA was significantly higher in fluoroquinolone-resistant isolates than in fluoroquinolone-sensitive isolates (42 of 57 [74%] and 16 of 34 [47%], respectively; Table Table1).1). Also, the prevalence of fluA differed depending on the phylogenetic origin (P < 0.001), with fluA significantly associated with group D (83% versus 45% in the remaining groups, P = 0.0002).

Further analysis revealed equal distribution of fluA in sensitive and resistant isolates belonging to group D (Table (Table1).1). In contrast, fluA was associated with resistance in isolates of group B2. This again is in agreement with other studies suggesting a relationship between the presence or absence of certain virulence genes and antimicrobial resistance only in group B2 (3, 7, 8) but not in group D (6).

In conclusion, we report here that the virulence-associated fluA gene is positively linked to fluoroquinolone resistance, particularly in E. coli belonging to phylogenetic group B2. To our knowledge, fluA has not been previously described in this connection and might provide another factor to understand the complex relationship between fluoroquinolone resistance and virulence in E. coli.

Acknowledgments

This work was supported by grants from the Swedish Research Council (57X-20356), ALF Project Funding, and Karolinska Institutet.

Footnotes

[down-pointing small open triangle]Published ahead of print on 2 December 2009.

REFERENCES

1. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558. [PMC free article] [PubMed]
2. Drews, S. J., S. M. Poutanen, T. Mazzulli, A. J. McGeer, A. Sarabia, S. Pong-Porter, Y. Rzayev, B. Willey, K. Green, and D. E. Low. 2005. Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. J. Clin. Microbiol. 43:4218-4220. [PMC free article] [PubMed]
3. Horcajada, J. P., S. Soto, A. Gajewski, A. Smithson, M. T. Jiménez de Anta, J. Mensa, J. Vila, and J. R. Johnson. 2005. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J. Clin. Microbiol. 43:2962-2964. [PMC free article] [PubMed]
4. Johnson, J. R., M. A. Kuskowski, K. Owens, A. Gajewski, and P. L. Winokur. 2003. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J. Infect. Dis. 188:759-768. [PubMed]
5. Moreno, E., G. Prats, M. Sabaté, T. Pérez, J. R. Johnson, and A. Andreu. 2006. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J. Antimicrob. Chemother. 57:204-211. [PubMed]
6. Olesen, B., F. Scheutz, M. Menard, M. N. Skov, H. J. Kolmos, M. A. Kuskowski, and J. R. Johnson. 2009. Three-decade epidemiological analysis of Escherichia coli O15:K52:H1. J. Clin. Microbiol. 47:1857-1862. [PMC free article] [PubMed]
7. Piatti, G., A. Mannini, M. Balistreri, and A. M. Schito. 2008. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J. Clin. Microbiol. 46:480-487. [PMC free article] [PubMed]
8. Takahashi, A., T. Muratani, M. Yasuda, S. Takahashi, K. Monden, K. Ishikawa, H. Kiyota, S. Arakawa, T. Matsumoto, H. Shima, H. Kurazono, and S. Yamamoto. 2009. Genetic profiles of fluoroquinolone-resistant Escherichia coli isolated from cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns. J. Clin. Microbiol. 47:791-795. [PMC free article] [PubMed]
9. Ulett, G. C., J. Valle, C. Beloin, O. Sherlock, J.-M. Ghigo, and M. A. Schembri. 2007. Functional analysis of antigen 43 in uropathogenic Esche-richia coli reveals a role in long-term persistence in the urinary tract. Infect. Immun. 75:3233-3244. [PMC free article] [PubMed]
10. Wang, H., J. L. Dzink-Fox, M. Chen, and S. B. Levy. 2001. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob. Agents Chemother. 45:1515-1521. [PMC free article] [PubMed]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)